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ABSTRACT (258 words) 
Introduction: Subjective fatigue has been recognised as an important, multi-component 
symptom in COPD. Pulmonary Rehabilitation (PR) improves fatigue component of the 
Chronic Respiratory Questionnaire, a quality of life (QoL) measure. However, it is not 
clear if all fatigue dimensions are affected equally. This study aims to evaluate changes 
in subjective multidimensional fatigue among people with COPD who participated in  
PR. 
Methods: Thirty seven stable COPD patients were recruited; 23 patients (15 male) 
mean age 68.5 (range 49-86) yrs, mean (SD) % predicted FEV1 45.3 (19.8); completed 
7-weeks of PR. Assessments (pre and post PR) consisted of the Multidimensional 
Fatigue Inventory (MFI-20), QoL (SGRQ), Anxiety and Depression (HADS), the 
London Chest Activity of Daily Living Scale (LCADL), muscle strength, incremental 
(ISWT) and endurance (ESWT) shuttle walk tests. The differences between pre and 
post PR fatigue were tested using Wilcoxon’s test and relationships with other 
outcomes were examined using Spearman’s correlation. 
Results: There were statistically significant improvements in Reduced Activity (RA) 
(p=0.01), General (GF) (p<0.01) and Physical Fatigue (PF) (p=0.03) components of 
MFI-20 after PR, but there were no differences in Motivation or Mental Fatigue 
(p>0.05). There were significant improvements in ISWT (p<0.05), ESWT (p<0.01) and 
muscle strength (p=0.03). Statistically significant correlations (p<0.05) were found 
between changes in GF and in both ISWT (r=-0.43) and SGRQ impact (r=0.46); and 
between RA and ESWT changes (r=-0.45). 
Conclusions: Some dimensions of fatigue in COPD are modifiable by a 7- week PR 
programme. Change in fatigue dimensions in COPD may be associated with a change 
in maximal or endurance walking distances or QoL.  
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INTRODUCTION 
 
Subjective fatigue is an important and highly prevalent symptom in Chronic Obstructive 
Pulmonary Disease (COPD) [1]. People with COPD experience greater fatigue than 
healthy older people [2-4] and this, in turn, is associated with the severity of the disease 
rather than age itself. COPD-related fatigue (COPD-RF) affects patients’ functional 
performance [5;6], quality of life (QoL) [2;7] and may be an important barrier to 
undertaking physical activity [8;9]. Fatigue, in COPD is a complex symptom, and as 
such a multidimensional approach is required to its assessment. The findings from 
regression studies revealed that dyspnoea, depression, muscle weakness, decreased 
exercise capacity, airway limitation, body weight and exercise de-saturation were 
indicators in the perception of COPD-RF [2;3;5;10]. Therefore, these factors should be 
considered when planning a comprehensive treatment of COPD-RF. 
Pulmonary rehabilitation (PR) is a well established gold standard of care for COPD 
patients, which improves patients’ dyspnoea, QoL and exercise tolerance [11;12]. 
Recent studies have also shown that cognitive function [13], depression and anxiety 
[14;15] may improve with PR. One meta-analysis demonstrated significant 
improvement in the fatigue subscale of a QoL questionnaire after PR [16]. However, 
there is little attention to this outcome in rehabilitation literature and only a few studies 
considered fatigue as a symptom-specific assessment [17;18]. Although some studies 
indicate that PR may somewhat modify fatigue in COPD [16;17], it is not clear if the 
separate general; physical; and psychological aspects of fatigue may be improved 
equally following PR. Exercise training is an important component of  PR leading to 
improvements in muscle strength and exercise tolerance [19-21], which in turn may 
influence physical components of COPD-RF. However, rehabilitation also aims to 
address psychological aspects of COPD using and education and behavioural 
approaches [22-25], these in turn may modify the motivational and cognitive aspects 
of fatigue. This study, therefore, aims to evaluate whether COPD-RF dimensions, 
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assessed with the MFI-20, change after a seven-week PR programme and if the 
changes in fatigue dimensions are associated with changes in other established 
outcome measures.   
 
METHODS 
Full ethical consent was obtained from the Royal Marsden Local Research Ethics 
Committee (London, UK). All patients gave written informed consent prior to entering 
the study.  
 
Subject recruitment  
Thirty seven stable COPD subjects (defined as FEV1/FVC ratio < 0.7) were recruited  
from those on the waiting list for PR at St. George’s Hospital, London (UK) until 
reaching a desired sample size (see statistical analysis). An invitation letter was sent 
with a return opt-out slip and those who agreed were contacted by phone. Diagnosis 
of COPD had been previously confirmed by a general practitioner or a chest physician 
and medication was optimised. Patients were excluded if they had unstable angina, 
significant co-morbidities, such as rheumatoid arthritis, stroke, carcinoma, psychiatric 
personality disorders, intermittent claudication or other mobility limiting conditions. 
Patients with other mild, stable and well controlled co-morbities were included e.g. 
osteoarthritis, hypertension or diet-controlled diabetes. 
  
Assessments  
Patients included in the study attended the hospital for an individual baseline 
assessment. Assessment was carried out over two days if necessary, for instance, 
when the patient was too tired to continue. After attendance of 14 rehabilitation 
sessions over at least seven and maximum of 10 weeks, the patients were reassessed 
at the separate follow up session within one week from the last PR session. Those 
who were unable to complete 14 sessions were classified as dropped-out. 
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Measurements taken included height (cm), weight (kg) and body composition, 
assessed using a non-invasive bioelectrical impedance technique (Body composition 
analyser, Tanita Ltd BC-418MA, UK). Baseline Forced Expiratory Volume in one 
second (FEV1) and Forced Vital Capacity (FVC) were assessed using spirometer Micro 
Plus MS03 (Micro Medical Ltd, Rochester UK) according to ERS/ATS 
recommendations [26]. 
 
Subjective fatigue was assessed using the Multidimensional Fatigue Inventory (MFI-
20), a 20-item self-report instrument designed to measure subjective fatigue [27;28]. 
The questionnaire asks patients to describe how they have been feeling lately. For 
issues of clarity this was specified as “within the last two weeks”. The tool consists of 
five dimensions covering General Fatigue (GF), Physical Fatigue (PF), Reduced 
Activity (RA), Reduced Motivation (RM) and Mental Fatigue (MF). Each dimension has 
4 items, each item scored from 1-5 with higher scores representing greater levels of 
fatigue. 
 
Mood status: All participants completed the Hospital Anxiety and Depression Scale 
(HADS). The HADS is a questionnaire designed to measure depressive and anxiety 
moods separately [29]. A score of 11 or higher for either of the components indicates 
probable presence of a mood disorder.   
 
Baseline breathlessness level was assessed using the Medical Research Council 
Dyspnoea Grade (MRC) [30]. Breathlessness during Daily Activities was assessed 
using the London Chest Activity of Daily Living Scale (LCADL) [31;31]. The 
questionnaire consists of 15 daily activities, with each scored 0 to 5. The total score 
ranging from 0 to 75 is calculated, with the higher score indicating more breathlessness 
during daily activities. 
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Health related QoL was assessed using Saint George’s Respiratory Questionnaire  
(SGRQ) [32].  
 
Maximal exercise tolerance was assessed using the Incremental Shuttle Walking 
Test (ISWT), an incremental, externally paced exercise capacity test conducted 
according to standardised procedure [33]. Endurance exercise tolerance was then 
assessed at 85% of peak oxygen uptake (VO2), estimated from ISWT, using the 
Endurance Shuttle Walking Test (ESWT) [34]. Prior to and after each test 
percutaneous arterial oxygen saturation (SpO2) and heart rate were measured using a 
pulse oxymeter (Pulsox-3i- Konika Minolta, Singapore) applied to the finger. Borg CR 
10 (Breathlessness) and Borg Rating of Perceived Exertion (RPE) scales were scored 
at the end of each test [35;36].  
 
Quadriceps maximal torque was measured using a “Cybex Norm™ Testing and 
Rehabilitation System”. Concentric knee extensions and flexions were performed and 
maximally at an angular velocity of 60°/sec. Maximum torque was recorded during 
isokinetic work of the 10-reperition as the best attempt of the dominant side. 
 
Pulmonary Rehabilitation programme 
Subjects underwent a seven week outpatient PR programme with two supervised 
sessions per week, based in St. George’s Hospital, London, UK. Hence, the completed 
programme consisted of 14 sessions. As this was a “rolling” programme, patients who 
missed a session(s) could continue beyond 7 weeks until they attended 14 supervised 
sessions for maximum of 10 weeks. Each session consisted of 1 hour exercise training 
and 30 minutes of education. The exercise training was designed as circuit training 
and consisted of an individually tailored programme of aerobic endurance or interval, 
and upper and lower limbs resistance training. Endurance or interval training were 
used to achieve exercise intensity of 60-80% VO2 peak based on ISWT estimation. 
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The higher intensity was promoted and gradual progression was encouraged each 
week. Each training session consisted of aerobic training which included cycling, 
treadmill walking and step climbing. Patients were also encouraged to exercise at 
home between hospital sessions according to an exercise diary given by the therapist. 
Education sessions were delivered by a multidisciplinary team and covered 
pathophysiology, benefits of exercise, self management, breathing control, sputum 
clearance, medication and oxygen, inhaler techniques, nutrition and diet, relaxation 
and smoking cessation. Patients were also taught strategies to cope with 
breathlessness, breathing control and energy conservation techniques.  
 
Statistical analysis 
 
Sample size calculation had been performed prior the study based on mean GF (SD) 
sub-score of MFI-20 (13.9 (4.2)) from a previous study by Breslin et al. [7]. Assuming 
change of 3.5 points in MFI-20, the study required minimum 22 patients at power 80% 
and p<0.05. Data from patients who completed 14 PR sessions or dropped out were 
collected and analysed. Mean and standard deviation (SD) for parametric, and median 
and inter-quartile range (IQR) for non-parametric variables were recorded. Differences 
in baseline measurements between the rehabilitation drop-out and completed groups 
were examined using independent samples parametric or non-parametric tests, as 
appropriate. Wilcoxon signed-rank tests were performed on the completed PR group 
to test for differences in pre and post PR results. Spearman’s rank correlation was 
used to identify associations between the changes in fatigue dimensions after PR and 
other changes in PR outcomes. In all tests a p-value < 0.05 was taken to indicate a 
statistically significant result. All statistical analysis was carried out in SPSS 15.0.  
 
RESULTS 
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Thirty seven COPD subjects entered the rehabilitation programme; of these, 23 
patients (15 male) completed the programme and were reassessed. Those who 
completed PR had a mean age of 68.5 years (range 49 - 86), their mean (SD) % 
predicted FEV1 was 45.3 (19.8) and FEV1/FVC ratio 0.44 (0.12). Comparison between 
this group of patients and those who dropped out from the rehabilitation programme at 
baseline showed no significant differences in initial fatigue level, age or airway 
obstruction severity. However, those who dropped out had significantly higher scores 
for both HADS depression (p = 0.03) and anxiety (p=0.03); and for SGRQ impact 
(p=0.01) and total (p = 0.02). See table 1 for details. 
 
Evaluation of changes in fatigue dimension scores after PR 
 
Most of the 23 patients who completed the rehabilitation programme showed 
improvements in fatigue score but improvements were not equally distributed across 
the 5 components of fatigue. A reduction in fatigue was observed in 16 patients for GF 
and PF scores, 14 for RA, 11 for RM and 9 for MF. See Figure 1 for the individuals’ 
fatigue dimension scores before and after PR.  
Median scores for all dimensions except PF vary little pre and post PR. Median scores 
post PR programme were statistically significantly lower for RA, GF and PF, but not for 
RM or MF. As can be seen in Figure 2 the IQR change little pre and post PR for GF, 
PF and RA. However, the IQR is reduced post PR for RM and MF, indicating smaller 
differences in the scores for the middle 50%. The comparison of median fatigue score 
before and after rehabilitation showed significant differences only in selected 
dimensions (see Table 2). 
 
Evaluation of changes in PR outcomes and their association with changes in 
fatigue scores. 
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Most patients improved their maximal and endurance walking distance. 17 out of 23 
improved on ISWT and 14 out of 20 on their ESWT. At baseline, 11 of the 23 patients 
showed de-saturation during exercise, defined as a fall of 4% to below 90%, but during 
reassessment post PR saturation fell in only 8 patients. Although not significant, there 
was a trend towards improvement in exercise de-saturation.  
 
There were significant differneces in ESWT, ISWT, SGRQ activity scores and mmTq 
between the start and the end of the PR programme. However, no significant 
differences were observed in BMI, total SGRQ, LCADL measures or HADS depression 
or anxiety scores. Summary statistics for PR outcome measures are presented in 
Table 3.  
 
Relationships between the change in fatigue dimensions following PR and change in 
the other measurements, as presented in Table 3, were assessed. There were 
moderate correlations between the change in GF and the change in ISWT (r=-0.43) 
and for RA and the change in ESWT (r=-0.45). No other significant.relationships were 
found. 
 
Discussion 
 
This study shows that subjective fatigue is modified following a modest seven week 
rehabilitation programme and the improvement is evident in three out of five 
dimensions of MFI-20. Previous studies demonstrated improvement in fatigue 
component health related QoL after PR as shown by a meta-analysis [16]. Although in 
a recent RCT [18] of 26 patients no improvement was demonstrated with regard to 
fatigue frequency, duration, severity or functional limitations following PR, the study 
was underpowered and the results may be subject to error. The selection of the tool 
the Fatigue Impact Scale and its responsiveness may also explain the lack of detected 
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improvement. However, other data presented by Peters et al. [17] a year earlier, 
implied that unidimentional fatigue, assessed using the Checklist Individual Strength, 
may be significantly reduced after PR.  
 
Our findings show that there are significant improvements in the Reduced Activity, 
General and Physical Fatigue components of MFI-20 but not in Reduced Motivation  
or Mental Fatigue. This study is the first to report changes in individual dimensions of 
fatigue following PR among patients with COPD. Although PR is a holistic programme, 
which is intended to address all areas of patients’ health, the improvement was 
demonstrated only in selected fatigue dimensions. There may be various explanations 
for this finding; our sample size calculation was based on the General Fatigue 
subscale, which might have not been adequately powered to detect changes in all 
dimensions. Moreover, the relatively short 7-week programme may be long enough to 
form changes in general and physical dimensions, but may be insufficient to modify 
the motivational or mental fatigue. Furthermore, during rehabilitation programme no 
ambulatory oxygen was used in order to normalise exercise hypoxaemia unless patient 
was using Long Term Oxygen Therapy or had SpO2 below 85% on exercise. In this 
cohort, none of the patients met these criteria therefore no oxygen was offered. An 
earlier study of fatigue predictors revealed an association between exercise de-
saturation and motivational, general and mental fatigue [3]. It is possible that, 
improvement in exercise oxygenation could have led to greater chages in motivational 
and mental fatigue. However, as ambulatory oxygen was not used to correct exercise 
de-saturation in this study this theory remains untested. Suprisingly, there was a trend 
torward an improvement in exercise oxygenation at the end of PR, which may be due 
to physiological adaptation following physical training or simply a pulsoxymetric 
variability [37]. Previous reports in this area are inconsistent [38;39]. 
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Furthermore, an essential component of all PR is physical exercise training and this 
study showed, as expected, good improvements in exercise tolerance and muscle 
strength, but not in psychological outcomes such as anxiety or depression. Depression 
has been shown to be an important predictor of COPD-RF [2;3] and the lack of 
individual cognitive therapy sessions or depression management in this programme 
may explain insignificant change in motivational and mental fatigue. However,  anxiety 
and depression in this cohort of patients were mostly within normal values with patients 
with higher scores more likely to drop out as reflected in recent findings by Hogg et al. 
[40]. As reported by Harrison and co-workers no  improvement in mood should be 
expected in patients with baseline low scores [41]. Similarly, the scores for motivational 
and mental fatigue were lower than for the 3 other dimensions, which may indicate 
mostly normal fatigue values for this cohort. Consequently, the scores for these two 
dimensions following PR were less likely to improve significantly. Future well powered 
studies are needed to investigate changes in these psychological dimensions. 
Furthermore, those patients with higher level of fatigue may show poor uptake and 
adherence with rehabilitation as shown by Hogg at al. [40] and assessment of fatigue 
may help in identifying this group of patients.  
 
Analysis of relationships between changes in fatigue and other outcome measures of 
PR revealed that the increase in maximal exercise tolerance and prolonged endurance 
walk was associated with the general and activity fatigue dimensions. Previously, 
studies of fatigue in COPD have shown that general and physical components of 
fatigue may be predicted by exercise tolerance and muscle strength [3;7;42]. These 
results lead to the hypothesis that certain dimensions of COPD-RF may be modified 
by increasing exercise capacity and endurance. In a recent randomised study of PR, 
effect of fatigue level on outome measures was investigated in patients with higher and 
lower baseline fatigue. Although both groups improved their walking distance following 
PR [43], the improvements in distance walked or endurance time achieved at the end 
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of PR were not maintained after 1 year in the high fatigue group. Also, recent 
conference data from two authors showed that lack of energy and tiredness are main 
barriers for physical activity [8;9]. These suggest that higher fatigue may not impact 
immediate outcomes of PR but it may affect them in a long term. Therefore, subjective 
fatigue may be one of the important factors considered in the rehabilitation process. 
Although change in other variables in our study, such as, muscle torque or de-
saturation did not relate to changes in fatigue, their role in fatigue improvement cannot 
be excluded [42;44]. Moreover, there were no changes to BMI following PR, which is 
in agreement with one other study [45].  
Due to limitations in the study design it is not possible to say unequivocally that the 
changes we observed in fatigue after pulmonary rehabilitation were solely brought 
about as a result of the rehabilitation. However, previous data from RCTs have 
indicated a positive effect of rehabilitation on fatigue score [16]. This study was 
designed, primarily, to test the response of MFI-20 to rehabilitation and to compare the 
magnitude of change across the dimensions of fatigue. Although this study has been 
conducted on a relatively small sample of 23 patients, changes in some of the fatigue 
dimensions have been identified. However, the size of this study does not allow 
exploration of other factors, such as, drop out reasons or ratio. Fatigue is associated 
with exacerbation rate [2] which may strongly influence attendance or a drop-out of 
rehabilitation [40;46]. Although we found no difference in fatigue levels between those 
who dropped out of the rehabilitation and those who completed, this evaluation was 
not powered to look at predictors of the drop-out and fatigue may well be an important 
cofounder or aspect of the drop-out. This may be a scope for future larger studies.   
 
Conclusion 
The findings from this study suggest that at least three components of MFI-20 are 
modifided after 7 week PR. The changes in reduced activity, general and physical 
fatigue, as might be expected, were associated with improvements in QoL, maximal or 
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endurance walking distance. However, it is still unclear whether motivational or mental 
components of fatigue are  modified by PR or whether other problem focused 
modalities are required to achieve improvement in all dimensions of COPD-RF. The 
multidimensional nature of fatigue requires a holistic approach to treatment which 
involves physical, nutritional and psychological interventions and it should be taken 
into consideration when planning individualised patient’s care. 
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